Detoxification Series · Part 1 of 5 · Liver · Bile

Liver, Bile, and the Detox Pathway Nobody Explains Properly

Detoxification is not a juice cleanse. It’s a two-phase enzymatic process in the liver — and Phase I without sufficient Phase II creates more toxic intermediates than you started with. This is the thing nobody mentions when they sell you a detox protocol.

Stephen Duncan FDN-P MSc · Detective Health · 2026 · Detoxification Series · Part 1

The wellness industry uses the word “detox” to sell things. That’s not what this article is about. What this article is about is what the liver actually does — the specific enzyme systems involved, why the sequence matters, what happens when the system is overloaded or incomplete, and what the gallbladder and bile have to do with any of it. If you understand the mechanism, you can support it appropriately. If you don’t, you end up doing the functional equivalent of opening a drain while the pipe is still blocked.

The liver performs somewhere in the region of 500 distinct functions. Detoxification is one cluster of them, but it’s a cluster that affects almost everything else — because if the liver can’t process and excrete what needs to come out, those compounds recirculate, accumulate in tissue, drive inflammation, disrupt hormone signalling, and burden every other system downstream. Understanding liver detox isn’t a niche interest. It’s a prerequisite for understanding why a lot of chronic health problems are persistent.

Phase I and Phase II — Why the Sequence Is Everything

Liver detoxification happens in two distinct phases, and the relationship between them is the thing that most detox content completely ignores.

Phase I — Transformation
CYP450 enzymes convert fat-soluble toxins into reactive intermediates
A family of enzymes called cytochrome P450 (CYP450) take fat-soluble compounds — hormones, drugs, environmental chemicals, metabolic waste products — and chemically modify them, usually through oxidation, reduction, or hydrolysis. The goal is to make them more water-soluble so they can be excreted. But in doing so, Phase I often creates reactive intermediates — compounds that are, temporarily, more chemically active and potentially more damaging than the original substance.
Phase II — Conjugation
Six conjugation pathways neutralise intermediates and prepare them for excretion
Phase II takes the reactive intermediates from Phase I and attaches them to other molecules — glucuronic acid, sulphate, glutathione, glycine, methyl groups, or acetyl groups — through six distinct conjugation pathways. This makes the compounds water-soluble, non-reactive, and ready for excretion through bile into the gut, or through the kidneys into urine. Without sufficient Phase II capacity, intermediates accumulate. This is where the damage happens.

The critical point: Phase I and Phase II need to be in balance. If Phase I is very active — stimulated by alcohol, caffeine, certain medications, or environmental chemicals — and Phase II is insufficient, the system backs up with reactive intermediates. This is the mechanism behind why some people feel significantly worse during a “detox” that stimulates Phase I (green juices, coffee enemas, certain supplements) without adequately supporting Phase II. They’re mobilising more than they can process.

Phase I without adequate Phase II doesn’t detoxify you. It transforms compounds into reactive intermediates and leaves them there. The cleanse that makes you feel terrible for a week is often doing exactly this.

What Phase II Actually Needs

Each of the six Phase II pathways depends on specific nutrients as cofactors. These aren’t optional. Without them, the pathway runs slowly or stalls:

Glucuronidation (the highest-volume Phase II pathway, handles oestrogen, bilirubin, many drugs): requires UDP-glucuronic acid, which depends on magnesium and B vitamins. Impaired glucuronidation is a primary mechanism behind oestrogen recirculation and the oestrogen dominance pattern.

Sulphation (handles steroid hormones, thyroid hormones, neurotransmitters, many environmental chemicals): requires sulphur amino acids — cysteine, methionine — and molybdenum. People with low dietary sulphur intake or molybdenum deficiency have compromised sulphation. This pathway is also easily saturated by high alcohol intake, which is one reason alcohol has such a pronounced effect on hormone clearance.

Glutathione conjugation (handles heavy metals, pesticides, many cancer-causing compounds, lipid peroxides): the most important antioxidant pathway in the liver. Glutathione synthesis requires glycine, cysteine, and glutamic acid. N-acetyl cysteine (NAC) is the most evidence-backed supplement for supporting this pathway because it directly provides cysteine. Glycine — found in collagen, bone broth, and gelatinous cuts of meat — is the rate-limiting amino acid for glutathione synthesis in many people eating low-protein or low-animal-food diets.

Methylation (handles catecholamines, histamine, heavy metals, arsenic, some hormones): requires methyl donors — SAMe, folate, B12, B6. MTHFR variants that impair the folate-to-methyltetrahydrofolate conversion reduce methylation capacity and are one of the most common functional reasons for impaired Phase II.

Amino acid conjugation (particularly glycine conjugation, handles benzoate, salicylates, bile acids): again, glycine is the key nutrient. Glycine deficiency — which is common because it’s found primarily in connective tissue of animals, not muscle meat — impairs both this pathway and glutathione synthesis simultaneously.

Acetylation (handles drugs, carcinogens, some environmental chemicals): requires acetyl-CoA, which depends on B5 and overall mitochondrial function. Impaired acetylation is associated with increased sensitivity to caffeine, some medications, and environmental chemicals.

The Gut as the Exit Route — Why the Story Doesn’t End at the Liver

Processed compounds from Phase II leave the liver in two ways: some go into the blood and are filtered by the kidneys into urine, and some go into bile and are excreted into the small intestine via the bile duct. The gut then needs to complete the job by carrying them through and out in stool.

This is where the gut-liver axis becomes clinically critical, and where a common and largely unrecognised failure point occurs: beta-glucuronidase.

Beta-glucuronidase is an enzyme produced by certain gut bacteria that cleaves the glucuronide bond — the conjugation that Phase II liver detoxification just applied to make those compounds safe for excretion. When beta-glucuronidase activity is elevated (which the GI-MAP measures directly), glucuronidated compounds are deconjugated in the gut and reabsorbed into circulation in their original reactive form. This is the recirculation cycle that drives oestrogen dominance, increases toxin reabsorption, and means the liver has to process the same compounds repeatedly rather than clearing them once.

The intervention is gut-specific: reducing beta-glucuronidase-producing bacteria through gut repair work, calcium-D-glucarate (which inhibits beta-glucuronidase activity), and sufficient fibre to maintain transit time and stool bulk so that compounds don’t have time to be reabsorbed before leaving.

Bile — The Underappreciated Half of Liver Function

The liver produces around a litre of bile per day. Bile has two jobs that most people have never thought about separately: it emulsifies dietary fat (breaking it into droplets small enough for lipase enzymes to act on, enabling fat-soluble nutrient absorption), and it carries the waste products of Phase II detoxification out of the liver and into the small intestine for excretion.

The gallbladder stores and concentrates bile between meals, releasing it in response to fat entering the duodenum. When fat is detected, cholecystokinin (CCK) signals the gallbladder to contract and release bile — a process that works correctly only if you’re actually eating fat. Low-fat diets, fat phobia, and the widespread practice of eating fat-free meals means the gallbladder contracts rarely and incompletely. Bile stagnates, becomes more concentrated, and can form sludge or stones. This is one of the less-discussed consequences of decades of low-fat dietary advice.

Signs of bile insufficiency — what to look for

Digestive: Bloating and belching after fatty meals · Pale, clay-coloured, or floating stools (fat malabsorption) · Nausea with greasy food · Right shoulder or upper right quadrant discomfort after eating · Constipation (bile stimulates peristalsis)

Nutritional: Fat-soluble vitamin deficiencies (A, D, E, K) despite adequate intake · Low cholesterol (bile is made from cholesterol — can indicate impaired synthesis) · Difficulty absorbing omega-3 fatty acids

Systemic: Elevated LDL on blood chemistry (impaired bile cholesterol recycling) · Elevated GGT (one of the most sensitive liver stress markers) · Impaired oestrogen clearance patterns on DUTCH · Dry skin, dry eyes

TUDCA and Bile Acid Support

Tauroursodeoxycholic acid — TUDCA — is a bile acid found naturally in small quantities in human bile and in larger quantities in bear bile (historically the source, now synthesised). It’s been used in clinical hepatology for decades to treat cholestasis (impaired bile flow) and certain liver conditions. In functional medicine, it’s used more broadly to support bile flow, protect hepatocytes (liver cells) under oxidative stress, and improve mitochondrial function — TUDCA has a specific protective effect on the mitochondrial membrane.

It’s one of the more evidence-backed liver support supplements, and unlike many “liver support” products, it has a clear mechanism. That said, it’s not the right first step for everyone. If bile flow is impaired because of gallstones, TUDCA can increase bile production without improving the obstruction. Assessment first, support after.

Ox bile — dried bovine bile extract — is a more straightforward digestive support for people who have had their gallbladder removed or who have clear evidence of bile acid insufficiency: pale stools, fat malabsorption, low fat-soluble vitamins. It provides exogenous bile acids to compensate for what the system isn’t producing or releasing adequately.

Bitter Foods and the Forgotten Digestive Reflex

Here is something that has been almost entirely lost from modern food culture: the taste of bitterness triggers a cephalic phase digestive response. Bitter taste receptors on the tongue send signals through the vagus nerve that stimulate saliva production, gastric acid secretion, enzyme release, and crucially for our purposes here, bile flow. This is the physiological purpose of the bitter taste — it evolved as a preparation signal for the digestive system to handle complex, potentially challenging foods.

Traditional cuisines the world over include bitter elements specifically because of this effect — aperitifs and digestifs, bitter salad leaves (radicchio, endive, dandelion), bitter herbs in cooking (gentian, dandelion root, artichoke leaf, milk thistle). The modern palate has largely eliminated bitterness from the food supply, replacing it with sweetness, because bitterness triggers avoidance as a toxin-detection signal. Refined foods that removed natural bitterness, combined with a food industry that learned to replace it with sweetness, have produced a population that never engages this reflex.

The practical implications are straightforward and require no supplement spending: eating bitter foods before meals (a small rocket or radicchio salad, a teaspoon of apple cider vinegar, a squeeze of lemon in water) stimulates the digestive cascade that includes bile release. Swedish bitters, artichoke leaf extract, and gentian root are the herbal equivalents. The bitterness is the active ingredient — encapsulated bitters that bypass the tongue lose most of their effect.

What Blood Chemistry Tells You About Liver Function

The standard liver panel most people receive — ALT, AST, ALP, GGT — is valuable when read in context, but the way it’s typically interpreted (anything within range is fine) misses most of the clinical picture.

GGT (gamma-glutamyl transferase) is the most sensitive marker of liver stress and is also a direct indicator of glutathione pathway activity. GGT is involved in the breakdown of extracellular glutathione and its recycling into cells. Elevated GGT — even within the standard reference range but above the functional optimal of around 15–20 U/L — suggests ongoing liver stress, elevated toxic load, or glutathione depletion. It rises with alcohol use, certain medications, fatty liver, bile duct obstruction, and environmental chemical exposure. Of all the liver markers, it’s the most clinically informative early warning signal.

ALT:AST ratio tells you something about the nature of the liver stress. AST is found in both liver and muscle; ALT is more liver-specific. An ALT:AST ratio above 1 suggests hepatocellular (liver cell) damage, which shifts toward fatty liver or hepatitis patterns. An ALT:AST ratio below 1 with elevated AST can suggest alcohol-related liver disease (where AST rises disproportionately) or muscle damage. Neither is obvious from looking at either marker in isolation.

ALP (alkaline phosphatase) elevation with normal or mildly elevated ALT/AST points toward bile duct issues rather than hepatocellular damage. In the functional interpretation, ALP combined with GGT elevation is a cholestasis pattern that warrants bile support as a clinical priority.

✦   ✦   ✦

The liver is not a passive filter that either works or doesn’t. It’s an active, nutrient-dependent metabolic system that performs well when fed appropriately, when the gut is completing the excretion it started, and when bile is flowing sufficiently to carry waste out. Supporting it isn’t complicated, but it requires understanding the actual mechanism — which is why most “detox” products fail. They address the word without understanding the biology.

The next post in this series covers fatty liver specifically and its relationship with insulin resistance — a connection that runs in both directions and explains why metabolic health and liver health are inseparable.

See your liver markers in clinical context

GGT, ALT:AST ratio, ALP, bilirubin, and Phase II cofactor status are all visible in the TDG Randox blood chemistry panel — interpreted against functional reference ranges, not just population averages.

The TDG Five-Test Programme →